Myeloid Therapeutics logo
Healthcare & Life Sciences

Myeloid Therapeutics

Myeloid Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.

series-b
series-b
Stage
2
Investors

About Myeloid Therapeutics

Myeloid Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Myeloid Therapeutics develops targeted therapies that modulate myeloid cells to treat immune diseases and cancer.

Explore Myeloid Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States